NCT02560857View on ClinicalTrials.gov

Clinical Evaluation of Quantiferon-Monitor to Predict Outcomes in Solid Organ Transplant Recipients

CompletedOBSERVATIONAL
Enrollment

151

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

September 30, 2016

Study Completion Date

May 31, 2018

Conditions
Immunity, Cellular
Interventions
OTHER

Quantiferon-Monitor assay

The QFT-Monitor assay is a recently developed non-pathogen specific immune assay based on immune activation of both innate and adaptive immunity.

Trial Locations (1)

M5G2N2

University Health Network, Toronto General Hospital, Multi-Organ Transplant, Toronto

All Listed Sponsors
lead

Deepali Kumar

OTHER

NCT02560857 - Clinical Evaluation of Quantiferon-Monitor to Predict Outcomes in Solid Organ Transplant Recipients | Biotech Hunter | Biotech Hunter